{
  "examSlug": "ptce",
  "examCode": "PTCE",
  "examName": "Pharmacy Technician Certification Exam",
  "outline": {
    "title": "PTCE Content Outline",
    "effective": "2026-01",
    "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
  },
  "domains": [
    {
      "id": "meds",
      "name": "Medications",
      "weight": 35
    },
    {
      "id": "safety",
      "name": "Patient Safety and Quality Assurance",
      "weight": 23.75
    },
    {
      "id": "orders",
      "name": "Order Entry and Processing",
      "weight": 22.5
    },
    {
      "id": "federal",
      "name": "Federal Requirements",
      "weight": 18.75
    }
  ],
  "topics": [
    {
      "slug": "brand-generic-classifications",
      "domainId": "meds",
      "outlineRef": "1.1",
      "question": "What brand, generic, and classification knowledge is on the PTCE?",
      "answer": "Knowledge Area 1.1 tests matching generic names, brand names, and therapeutic classifications. A typical item asks which generic corresponds to a brand, or which class a named drug belongs to. This is the first required area in the Medications domain (35% of the exam).",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.1",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "therapeutic-duplications",
      "domainId": "meds",
      "outlineRef": "1.2",
      "question": "What is a therapeutic duplication on the PTCE?",
      "answer": "Knowledge Area 1.2 covers two drugs that treat the same condition through the same or overlapping pathways. The technician is expected to recognize the overlap and flag it for the pharmacist. Combining an ACE inhibitor with an ARB is a common example of same-pathway duplication.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.2",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "drug-interactions-contraindications",
      "domainId": "meds",
      "outlineRef": "1.3",
      "question": "Which interaction types appear on the PTCE?",
      "answer": "Knowledge Area 1.3 lists common or life-threatening interactions and contraindications across drug\u2013drug, drug\u2013dietary supplement, drug\u2013laboratory, drug\u2013nutrient, and drug\u2013disease pairs. The task is to recognize a listed interaction or contraindication and route it to the pharmacist, not to redesign therapy.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.3",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "strengths-doses-dosage-forms",
      "domainId": "meds",
      "outlineRef": "1.4",
      "question": "How are strengths, doses, and dosage forms tested?",
      "answer": "Knowledge Area 1.4 (calculation-flagged) covers strengths and doses, dosage forms, routes, special handling or administration instructions, and duration of therapy. Items may ask whether a prescribed form exists, whether a route matches the product, or how long a labeled course runs.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.4",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "routes-and-special-administration",
      "domainId": "meds",
      "outlineRef": "1.4",
      "question": "What special handling and administration instructions are in scope?",
      "answer": "The same 1.4 area includes routes of administration and special handling or administration instructions\u2014for example shake-well suspensions, do-not-crush products, or devices that must be primed. Those instructions come from the product labeling, not from compounding procedures.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.4",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "side-effects-adverse-effects-allergies",
      "domainId": "meds",
      "outlineRef": "1.5",
      "question": "How does the PTCE treat side effects, adverse effects, and allergies?",
      "answer": "Knowledge Area 1.5 covers common or severe side effects, adverse effects, and allergies. Technicians identify a listed reaction or documented allergy and alert the pharmacist. Distinguishing a true allergy from an intolerance is a pharmacist decision.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.5",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "medication-indications",
      "domainId": "meds",
      "outlineRef": "1.6",
      "question": "Are medication indications on the PTCE?",
      "answer": "Yes. Knowledge Area 1.6 tests common labeled indications\u2014what a medication is used for. Items typically pair a drug or class with its primary use rather than asking for off-label specialty regimens.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.6",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "drug-stability-insulin-suspensions",
      "domainId": "meds",
      "outlineRef": "1.7",
      "question": "What stability facts are tested for insulin, suspensions, and injectables?",
      "answer": "Knowledge Area 1.7 (calculation-flagged) covers stability of oral suspensions, insulins, reconstitutable products, injectables, and vaccinations. Typical facts include whether an unopened insulin vial is refrigerated, how long a reconstituted antibiotic is good, or that a product must not be frozen. Nonsterile compounding procedures are not a current PTCE knowledge area.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.7",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "medication-storage-temperature-light",
      "domainId": "meds",
      "outlineRef": "1.8",
      "question": "What storage conditions does the PTCE expect?",
      "answer": "Knowledge Area 1.8 covers proper storage: temperature ranges, light sensitivity, and restricted access. Unopened manufacturer insulin is a common refrigerated example (2\u20138 \u00b0C). Light-sensitive products stay in original packaging. Controlled substances follow restricted-access rules in Federal Requirements as well.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.8",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "reconstitutable-products-beyond-compounding",
      "domainId": "meds",
      "outlineRef": "1.7",
      "question": "Is reconstitution on the current PTCE?",
      "answer": "Stability of reconstitutable products is in Knowledge Area 1.7. That means beyond-use time and storage after a manufacturer product is mixed as labeled. Procedures to compound nonsterile products, and physical/chemical incompatibilities written as compounding steps, were removed from the PTCE outline effective January 2026.",
      "citation": {
        "label": "PTCB, PTCE Job Analysis Study (outline changes effective January 2026)",
        "url": "https://ptcb.org/news/ptce-job-analysis-study/"
      }
    },
    {
      "slug": "high-alert-and-lasa",
      "domainId": "safety",
      "outlineRef": "3.1",
      "question": "What are high-alert and LASA medications on the PTCE?",
      "answer": "Knowledge Area 3.1 covers high-alert or high-risk medications and look-alike/sound-alike (LASA) pairs. High-alert drugs cause heightened harm when used in error (for example anticoagulants or insulin). LASA pairs are drugs whose names or packaging can be confused. The exam tests recognition and prevention, not a standalone narrow-therapeutic-index list\u2014that former knowledge area was removed for 2026.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.1",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "tall-man-lettering",
      "domainId": "safety",
      "outlineRef": "3.2",
      "question": "Why does Tall Man lettering appear on the PTCE?",
      "answer": "Tall Man lettering is listed in Knowledge Area 3.2 as an error-prevention strategy. Mixed-case letters highlight the differing part of two similar names so they are harder to mix up during selection. It is used with other safeguards such as separated inventory and barcode checks.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.2",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "error-prevention-barcodes-zeros",
      "domainId": "safety",
      "outlineRef": "3.2",
      "question": "Which error-prevention strategies are in the current outline?",
      "answer": "Knowledge Area 3.2 names matching the order to the correct patient, Tall Man lettering, separating inventory, leading zeros and avoiding trailing zeros, barcode use, and limiting error-prone abbreviations. These are system controls, not compounding technique.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.2",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "pharmacist-intervention-dur",
      "domainId": "safety",
      "outlineRef": "3.3",
      "question": "When must a technician involve the pharmacist?",
      "answer": "Knowledge Area 3.3 (calculation-flagged) lists issues that require pharmacist intervention: drug utilization review (DUR), adverse drug events, OTC recommendations, therapeutic substitution, misuse, adherence, post-immunization care, allergies, and drug interactions. The technician identifies the issue and stops for pharmacist review.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.3",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "otc-recommendation-limits",
      "domainId": "safety",
      "outlineRef": "3.3",
      "question": "Can a technician recommend an OTC product?",
      "answer": "OTC recommendation is listed in 3.3 as an issue that requires pharmacist intervention. Selecting a product for a patient\u2019s symptom is a pharmacist function. The technician can gather the request and the profile facts, then hand the decision to the pharmacist.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.3",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "medwatch-reporting",
      "domainId": "safety",
      "outlineRef": "3.4",
      "question": "What is MedWatch and when is it used?",
      "answer": "Knowledge Area 3.4 includes MedWatch among event-reporting procedures. MedWatch is the FDA safety-reporting program for serious adverse events, product quality problems, and medication errors involving human medical products. Reports support FDA safety actions; they do not replace internal pharmacy incident reporting.",
      "citation": {
        "label": "FDA, MedWatch: The FDA Safety Information and Adverse Event Reporting Program",
        "url": "https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program"
      }
    },
    {
      "slug": "vaers-reporting",
      "domainId": "safety",
      "outlineRef": "3.4",
      "question": "What is VAERS on the PTCE?",
      "answer": "VAERS is named in Knowledge Area 3.4. The Vaccine Adverse Event Reporting System is the national system co-managed by CDC and FDA for reports of possible vaccine side effects. Post-immunization problems that need clinical judgment also sit in 3.3 as pharmacist-intervention items.",
      "citation": {
        "label": "CDC / FDA, Vaccine Adverse Event Reporting System (VAERS)",
        "url": "https://vaers.hhs.gov/"
      }
    },
    {
      "slug": "near-miss-rca-cqi",
      "domainId": "safety",
      "outlineRef": "3.4",
      "question": "How do near miss, RCA, and CQI show up on the exam?",
      "answer": "Knowledge Area 3.4 groups near miss, root-cause analysis (RCA), and continuous quality improvement (CQI) with other event-reporting procedures. A near miss is an error that was caught before it reached the patient. RCA looks for system causes. CQI is the ongoing process of measuring and improving those systems.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.4",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "types-of-prescription-errors",
      "domainId": "safety",
      "outlineRef": "3.5",
      "question": "What types of prescription errors does the PTCE name?",
      "answer": "Knowledge Area 3.5 (calculation-flagged) lists incorrect dose, quantity, patient, drug, and route of administration. Recognizing the wrong-element pattern is the tested skill. Preventing those errors uses the 3.2 strategies (patient match, barcodes, zeros, abbreviations).",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.5",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "infection-prevention-ppe-trays",
      "domainId": "safety",
      "outlineRef": "3.6",
      "question": "What infection-prevention steps are on the PTCE?",
      "answer": "Knowledge Area 3.6 covers infection-prevention procedures and cleaning standards: handwashing, personal protective equipment, and cleaning counting trays, countertops, and equipment. A penicillin-residue tray used for another patient\u2019s tablets is a classic contamination example.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 3.6",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "calculations-ratios-conversions",
      "domainId": "orders",
      "outlineRef": "4.1",
      "question": "Which calculations are on the current PTCE?",
      "answer": "Knowledge Area 4.1 (calculation-flagged) covers formulas, calculations, ratios, proportions, conversions, days supply, quantity, dose, concentration, and dilutions, plus Sig codes and medical terminology. Alligations were removed from this area for the January 2026 outline and are not current exam content.",
      "citation": {
        "label": "PTCB, PTCE Job Analysis Study (alligations removed from 4.2 / current 4.1)",
        "url": "https://ptcb.org/news/ptce-job-analysis-study/"
      }
    },
    {
      "slug": "sig-codes-and-abbreviations",
      "domainId": "orders",
      "outlineRef": "4.1",
      "question": "Which Sig codes and abbreviations should you know?",
      "answer": "Knowledge Area 4.1 explicitly names Sig codes such as b.i.d. and t.i.d., Roman numerals, abbreviations, medical terminology, and symbols used for days supply, quantity, and dose. Error-prone abbreviations are also limited under Patient Safety 3.2, so the same shorthand can be a calculation item and a safety item.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 4.1",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "days-supply-and-quantity",
      "domainId": "orders",
      "outlineRef": "4.1",
      "question": "How is days supply calculated on the PTCE?",
      "answer": "Days supply is listed in 4.1 with quantity and dose. The usual relationship is quantity dispensed divided by the amount used per day. Example: 60 tablets of a drug taken 1 tablet twice daily is a 30-day supply. Unit conversions must be finished before that division.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 4.1",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "dose-concentration-dilutions",
      "domainId": "orders",
      "outlineRef": "4.1",
      "question": "Are concentration and dilution problems still on the exam?",
      "answer": "Yes. Concentration and dilutions remain in Knowledge Area 4.1. That means using ratios and proportions to find a dose or a diluted strength from labeled products. It does not include alligation grids or procedures to compound nonsterile mixtures; those were removed from the PTCE effective January 2026.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 4.1",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "metric-and-household-conversions",
      "domainId": "orders",
      "outlineRef": "4.1",
      "question": "Which unit conversions are in scope?",
      "answer": "Conversions sit in 4.1 with ratios and proportions. Common pairs are metric mass and volume (mg, g, mL) and household measures used on labels (teaspoon, tablespoon) when a days-supply or dose item requires them. Finish the conversion, then complete the ratio.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 4.1",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "administration-supplies-devices",
      "domainId": "orders",
      "outlineRef": "4.2",
      "question": "What administration supplies are tested?",
      "answer": "Knowledge Area 4.2 (calculation-flagged) covers equipment and supplies required for drug administration: diabetic supplies, inhaler spacers, oral and injectable syringes, filters, dilution solutions, immunization supplies, and nebulizers. Items ask which device matches the prescribed product.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 4.2",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "ndc-lot-expiration",
      "domainId": "orders",
      "outlineRef": "4.3",
      "question": "How are NDC, lot, and expiration used on the PTCE?",
      "answer": "Knowledge Area 4.3 (calculation-flagged) covers National Drug Code (NDC) numbers, lot numbers, and expiration dates. The NDC identifies labeler, product, and package size. Lot and expiration support recall response, dating checks, and inventory removal.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 4.3",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "ndc-package-size",
      "domainId": "orders",
      "outlineRef": "4.3",
      "question": "What do the segments of an NDC mean?",
      "answer": "An NDC is a three-segment identifier: labeler, product, and package. Package-size differences appear in the last segment, which is why two bottles of the same strength can have different NDCs. That identifier is also used when tracing product under DSCSA in Federal Requirements 2.6.",
      "citation": {
        "label": "FDA, National Drug Code Directory",
        "url": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory"
      }
    },
    {
      "slug": "returns-reverse-distribution",
      "domainId": "orders",
      "outlineRef": "4.4",
      "question": "What happens to expired or unusable stock?",
      "answer": "Knowledge Area 4.4 covers identifying and returning dispensable, non-dispensable, and expired medications and supplies, including credit return, return to stock, and reverse distribution. Return-to-stock is for a labeled product that never left pharmacy control. Reverse distribution handles expired or unusable inventory through an authorized reverse distributor.",
      "citation": {
        "label": "PTCB PTCE Content Outline (effective January 2026), Knowledge Area 4.4",
        "url": "https://www.ptcb.org/credentials/certified-pharmacy-technician"
      }
    },
    {
      "slug": "hazardous-and-p-list-waste",
      "domainId": "federal",
      "outlineRef": "2.1",
      "question": "What federal waste rules apply in the pharmacy?",
      "answer": "Knowledge Area 2.1 covers federal storage, handling, and disposal rules for non-hazardous, hazardous (including P-list), and pharmacological substances and wastes. P-listed commercial chemical products are acute hazardous wastes when discarded as those chemicals. Pharmacy disposal must follow the applicable EPA hazardous-waste rules, not ordinary trash practice.",
      "citation": {
        "label": "40 CFR 261.33 \u2014 Discarded commercial chemical products (P- and U-lists)",
        "url": "https://www.ecfr.gov/current/title-40/chapter-I/subchapter-I/part-261/subpart-D/section-261.33"
      }
    },
    {
      "slug": "dea-controlled-substance-schedules",
      "domainId": "federal",
      "outlineRef": "2.2",
      "question": "How are DEA schedules tested?",
      "answer": "Knowledge Area 2.2 (calculation-flagged) covers federal requirements for controlled-substance prescriptions\u2014new, refill, and transfer\u2014and DEA schedules. Schedules I\u2013V are defined by accepted medical use and abuse potential. Schedule II products have the tightest prescription and refill limits.",
      "citation": {
        "label": "21 CFR Part 1308 \u2014 Schedules of Controlled Substances",
        "url": "https://www.ecfr.gov/current/title-21/chapter-II/part-1308"
      }
    },
    {
      "slug": "controlled-substance-prescriptions",
      "domainId": "federal",
      "outlineRef": "2.2",
      "question": "What federal rules apply to new, refill, and transfer controlled prescriptions?",
      "answer": "The same 2.2 area tests new controlled prescriptions, refills, and transfers. Schedule II prescriptions generally may not be refilled. Schedule III\u2013V refill and transfer limits are set in the federal prescription rules. State law may be stricter; the PTCE item is the federal floor.",
      "citation": {
        "label": "21 CFR Part 1306 \u2014 Prescriptions",
        "url": "https://www.ecfr.gov/current/title-21/chapter-II/part-1306"
      }
    },
    {
      "slug": "controlled-substance-inventory-security",
      "domainId": "federal",
      "outlineRef": "2.3",
      "question": "What federal duties cover receiving, storing, and losing controlled substances?",
      "answer": "Knowledge Area 2.3 covers receiving, storing, ordering, labeling, dispensing, returning, take-back, loss or theft, and destruction of controlled substances. Significant loss or theft is reported to DEA. Storage must prevent diversion.",
      "citation": {
        "label": "21 CFR 1301.76 \u2014 Other security controls for practitioners",
        "url": "https://www.ecfr.gov/current/title-21/chapter-II/part-1301/subject-group-ECFRf4c5d1de1d0a7b6/section-1301.76"
      }
    },
    {
      "slug": "take-back-and-destruction",
      "domainId": "federal",
      "outlineRef": "2.3",
      "question": "How do take-back programs fit the outline?",
      "answer": "Take-back programs are named in Knowledge Area 2.3 with returning and destroying controlled substances. Patients use authorized collectors or periodic take-back events. Staff destruction of pharmacy inventory follows DEA registrant rules, which are separate from a consumer take-back event.",
      "citation": {
        "label": "DEA Diversion Control Division, Drug Disposal Information",
        "url": "https://www.deadiversion.usdoj.gov/drug_disposal/drug-disposal.html"
      }
    },
    {
      "slug": "pseudoephedrine-cmea",
      "domainId": "federal",
      "outlineRef": "2.4",
      "question": "What federal limits apply to pseudoephedrine?",
      "answer": "Knowledge Area 2.4 lists pseudoephedrine among federal restricted-drug programs. Retail sales of scheduled listed chemical products are limited by daily and 30-day amounts, require photo ID, and are logged. Those Combat Methamphetamine Epidemic Act controls sit beside REMS in the same knowledge area.",
      "citation": {
        "label": "21 USC 830 \u2014 Regulation of listed chemicals and certain machines",
        "url": "https://www.law.cornell.edu/uscode/text/21/830"
      }
    },
    {
      "slug": "rems-restricted-programs",
      "domainId": "federal",
      "outlineRef": "2.4",
      "question": "What is a REMS on the PTCE?",
      "answer": "Knowledge Area 2.4 names Risk Evaluation and Mitigation Strategies (REMS) with other restricted-drug processing requirements. A REMS is an FDA-required safety program for certain medications. Technician work is to follow the listed steps\u2014authorization, documentation, or restricted dispensing\u2014not to waive them.",
      "citation": {
        "label": "FDA, Risk Evaluation and Mitigation Strategies (REMS)",
        "url": "https://www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems"
      }
    },
    {
      "slug": "fda-medication-recalls",
      "domainId": "federal",
      "outlineRef": "2.5",
      "question": "How are medication recalls tested?",
      "answer": "Knowledge Area 2.5 is FDA requirements for medication recalls. Recalls are actions to remove or correct a product, classified by the risk of harm (Class I most serious). Pharmacy response uses lot and NDC data from Order Entry 4.3 to pull affected stock.",
      "citation": {
        "label": "FDA, Recalls, Market Withdrawals, & Safety Alerts",
        "url": "https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts"
      }
    },
    {
      "slug": "dscsa-serialization-tracing",
      "domainId": "federal",
      "outlineRef": "2.6",
      "question": "What did DSCSA add to the 2026 PTCE?",
      "answer": "Knowledge Area 2.6 is new on the January 2026 outline: FDA product serialization, tracking, tracing, handling, and quarantining under the Drug Supply Chain Security Act (DSCSA). Trading partners must be able to trace certain prescription packages and quarantine suspect or illegitimate product.",
      "citation": {
        "label": "FDA, Drug Supply Chain Security Act (DSCSA)",
        "url": "https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa"
      }
    },
    {
      "slug": "pharmacy-technician-outlook",
      "domainId": "orders",
      "outlineRef": "labor",
      "question": "What does BLS publish for pharmacy technicians?",
      "answer": "The Occupational Outlook Handbook entry for pharmacy technicians reports employment, median pay, and projected growth for the occupation that the PTCE credential serves. Use the current handbook figures when quoting pay or growth; they are labor-market statistics, not exam scoring rules.",
      "citation": {
        "label": "BLS Occupational Outlook Handbook, Pharmacy Technicians",
        "url": "https://www.bls.gov/ooh/healthcare/pharmacy-technicians.htm"
      }
    }
  ]
}
